Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity

    Grunvald, Eduardo; Shah, Raj; Hernaez, Ruben; Chander, Apoorva Krishna; Teigen, Levi M; Sultan, Shahnaz; Sigh, Siddarth; Daviikov, Perica.
    Gastroenterology; 163 (5), 2022
    Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
    Factores de Riesgo de Enfermedad Cardiaca, Resistencia a la Insulina, Obesidad/tratamiento farmacológico, Depresores del Apetito, Hipoglucemiantes/uso terapéutico, Diabetes Mellitus Tipo 2/prevención & control, Topiramato/uso terapéutico, Fármacos Antiobesidad/uso terapéutico
    Texto completo

    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea

    Lembo, Anthony; Sultan, Shahnaz; Chang, Lin; Heidelbaugh, Joel; Smalley, Walter; Verne, Nicholas.
    Gastroenterology; 163 (1), 2022
    Background & aims: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant disease burden. This American Gastroenterological Association Guideline is intended to support practitioners in decisions about the use of medications for the pharmacological man...
    Síndrome del Colon Irritable/tratamiento farmacológico, Calidad de Vida, Fármacos Gastrointestinales/uso terapéutico, Antidiarreicos/uso terapéutico, Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico, Diarrea/tratamiento farmacológico
    Texto completo

    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation

    Chang, Lin; Sultan, Shahnaz; Lembo, Anthony; Verne, Nicholas; Smalley, Walter; Heidelbaugh, Joel.
    Gastroenterology; 163 (1), 2022
    Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS-C and...
    Polietilenglicoles/uso terapéutico, Lubiprostona/uso terapéutico, Calidad de Vida, Síndrome del Colon Irritable/tratamiento farmacológico, Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico, Estreñimiento/tratamiento farmacológico
    Texto completo